Man Group Portfolio holdings
AUM
$62.7B
Turnover
25.36%
1-Year Est. Return
29.77%
This Fund
S&P 500
This Quarter
Est. Return
-1.99%
1 Year Est. Return
+29.77%
3 Year Est. Return
+99.46%
5 Year Est. Return
+125.78%
10 Year Est. Return
–
AUM
$55.1B
AUM Growth
-$3.71B
(-6.3%)
Cap. Flow
-$2.01B
Cap. Flow
% of AUM
-3.65%
Top 10 Holdings %
Top 10 Hldgs %
15.88%
Holding
2,628
New
414
Increased
1,064
Reduced
775
Closed
261
Avg Time Held Equity + Options
1.2
years
Top 10 Avg Time Held Equity + Options
1.5
years
Top 20 Avg Time Held Equity + Options
1
year
Avg Time Held Equity only
1.2
years
Top 10 Avg Time Held Equity only
1.5
years
Top 20 Avg Time Held Equity only
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HDFC Bank
HDB
|
+$185M |
| 2 |
PepsiCo
PEP
|
+$176M |
| 3 |
TE Connectivity
TEL
|
+$166M |
| 4 |
Ford
F
|
+$131M |
| 5 |
3M
MMM
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$418M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$352M |
| 3 |
Amazon
AMZN
|
+$296M |
| 4 |
NVIDIA
NVDA
|
+$237M |
| 5 |
Eaton
ETN
|
+$195M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.85% |
| 2 | Miscellaneous | 14.37% |
| 3 | Financials | 10.33% |
| 4 | Healthcare | 9.99% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2126
Gen Digital
GEN
$14.2B
| $294K | ﹤0.01% |
15,594
-215,473
| -93% | -$4.99M |
2023 Q4
9 quarters
|
|
2127
Precigen
PGEN
$2.64B
| $292K | ﹤0.01% |
+75,439
| New | +$310K |
2026 Q1
0 quarters
|
|
2128
Protolabs
PRLB
$2.13B
| $292K | ﹤0.01% |
+5,114
| New | +$297K |
2026 Q1
0 quarters
|
|
2129
Astec Industries
ASTE
$916M
| $289K | ﹤0.01% |
5,372
-15,351
| -74% | -$823K |
2025 Q4
1 quarter
|
|
2130
Bowman Consulting
BWMN
$710M
| $287K | ﹤0.01% |
+10,090
| New | +$329K |
2026 Q1
0 quarters
|
|
2131
Septerna Inc
SEPN
$1.7B
| $285K | ﹤0.01% |
+11,858
| New | +$312K |
2026 Q1
0 quarters
|
|
2132
LuxExperience B.V.
LUXE
$1.3B
| $285K | ﹤0.01% |
+35,616
| New | +$306K |
2026 Q1
0 quarters
|
|
2133
Trinity Capital Inc
TRIN
$1.58B
| $285K | ﹤0.01% |
+19,361
| New | +$299K |
2026 Q1
0 quarters
|
|
2134
Tidewater
TDW
$4.12B
| $283K | ﹤0.01% |
+3,392
| New | +$236K |
2026 Q1
0 quarters
|
|
2135
Caleres
CAL
$422M
| $283K | ﹤0.01% |
26,878
+8,774
| +48% | +$105K |
2025 Q3
2 quarters
|
|
2136
Sagimet Biosciences
SGMT
$535M
| $281K | ﹤0.01% |
53,777
+18,171
| +51% | +$101K |
2025 Q3
2 quarters
|
|
2137
Tanger
SKT
$3.94B
| $280K | ﹤0.01% |
8,228
-4,619
| -36% | -$159K |
2025 Q1
4 quarters
|
|
2138
Evertec
EVTC
$1.85B
| $277K | ﹤0.01% |
+9,820
| New | +$279K |
2026 Q1
0 quarters
|
|
2139
RPC Inc
RES
$1.32B
| $277K | ﹤0.01% |
39,129
+26,596
| +212% | +$166K |
2025 Q2
3 quarters
|
|
2140
Mineralys Therapeutics
MLYS
$1.84B
| $275K | ﹤0.01% |
+10,139
| New | +$297K |
2026 Q1
0 quarters
|
|
2141
DELISTED
American Express Global Business Travel
GBTG
| $273K | ﹤0.01% |
48,897
-5,471
| -10% | -$34K |
2024 Q3
6 quarters
|
|
2142
Evolus
EOLS
$477M
| $272K | ﹤0.01% |
66,243
+22,839
| +53% | +$111K |
2024 Q4
5 quarters
|
|
2143
QuinStreet
QNST
$895M
| $271K | ﹤0.01% |
22,530
+11,241
| +100% | +$143K |
2025 Q2
3 quarters
|
|
2144
4D Molecular Therapeutics
FDMT
$674M
| $270K | ﹤0.01% |
28,983
+1,949
| +7% | +$17K |
2025 Q1
4 quarters
|
|
2145
Black Rock Coffee Bar Inc
BRCB
$160M
| $269K | ﹤0.01% |
+20,793
| New | +$337K |
2026 Q1
0 quarters
|
|
2146
Omega Healthcare
OHI
$13.7B
| $266K | ﹤0.01% |
+6,062
| New | +$277K |
2026 Q1
0 quarters
|
|
2147
Virtu Financial
VIRT
$4.9B
| $261K | ﹤0.01% |
5,932
-61,188
| -91% | -$2.38M |
2025 Q3
2 quarters
|
|
2148
J. Jill
JILL
$360M
| $259K | ﹤0.01% |
+22,577
| New | +$361K |
2026 Q1
0 quarters
|
|
2149
Iovance Biotherapeutics
IOVA
$6.44B
| $257K | ﹤0.01% |
73,082
+18,561
| +34% | +$59.4K |
2025 Q3
2 quarters
|
|
2150
First Internet Bancorp
INBK
$221M
| $256K | ﹤0.01% |
12,570
+1,860
| +17% | +$38.9K |
2023 Q4
9 quarters
|
|
Similar funds
NC
Man Group's Q1 2026 Portfolio in Review
As of Q1 2026, Man Group held 2,628 positions worth $55.1B, down 6.3% from $58.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Man Group withdrew a net $2.01B in Q1 2026, closing 261 positions and reducing 775 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Miscellaneous and Financials.
Against the trend, Man Group opened a new position in AstraZeneca worth $122M.
- Man Group's largest Q1 2026 buy was AstraZeneca: 628,476 shares worth $122M.
- Man Group added most to HDFC Bank in Q1 2026, an estimated $185M increase.
- Man Group's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $352M.
- Man Group fully exited State Street SPDR S&P 500 ETF Trust in Q1 2026, selling an estimated $418M.
- Man Group's ten largest holdings make up 16% of its $55.1B portfolio in Q1 2026.
- Man Group opened 414 new positions and closed 261 in Q1 2026.
- Man Group's portfolio value fell 6.3% quarter-over-quarter to $55.1B.
Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.